Cannabidiol – Recent Advances

@article{Mechoulam2007CannabidiolR,
  title={Cannabidiol – Recent Advances},
  author={Raphael Mechoulam and Maximilian Peters and Eric Murillo-Rodr{\'i}guez and Lum{\'i}r Ondřej Hanu{\vs}},
  journal={Chemistry \& Biodiversity},
  year={2007},
  volume={4}
}
The aim of this review is to present some of the recent publications on cannabidiol (CBD; 2), a major non‐psychoactive constituent of Cannabis, and to give a general overview. Special emphasis is laid on biochemical and pharmacological advances, and on novel mechanisms recently put forward, to shed light on some of the pharmacological effects that can possibly be rationalized through these mechanisms. The plethora of positive pharmacological effects observed with CBD make this compound a highly… 
An Overview on Medicinal Chemistry of Synthetic and Natural Derivatives of Cannabidiol
TLDR
This review provides an overview of the chemical structure of natural and synthetic CBD derivatives including the molecular targets associated with these compounds.
Potential Effects of Cannabidiol as a Wake-Promoting Agent
TLDR
This review will provide experimental evidence regarding the potential role of CBD as a wake-inducing drug and investigate the pharmacological properties of CBD with significant findings.
Cannabidiol, extracted from Cannabis sativa, selectively inhibits inflammatory hypermotility in mice
TLDR
The effect of cannabidiol on intestinal motility in normal (control) mice and in mice with intestinal inflammation is investigated.
Human Metabolites of Cannabidiol: A Review on Their Formation, Biological Activity, and Relevance in Therapy
TLDR
Current knowledge on the pharmacokinetics and metabolic fate of CBD in humans is summarized, studies on the biological activity of CBD metabolites either in vitro or in vivo are reviewed, and relevant drug–drug interactions are discussed.
Emerging Roles of Cannabinoids and Synthetic Cannabinoids in Clinical Experimental Models.
TLDR
This chapter provides an overview of the endocannabinoid system under certain physiopathological conditions, with a focus on neurological, oncologic, and metabolic disorders.
the role of cannabinoids in the treatment of children with cancer
TLDR
Cannabinoids are a heterogeneous group of compounds that exhibit activity by binding to specific receptors called cannabinoid receptors, and the synthetic analogs of both groups are called synthetic cannabinoids.
Cannabinoids-Promising Antimicrobial Drugs or Intoxicants with Benefits?
  • P. Klahn
  • Biology, Medicine
    Antibiotics
  • 2020
TLDR
It is time to discuss whether cannabinoids are promising antimicrobial drug candidates or overhyped intoxicants with benefits.
Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action.
  • A. Zuardi
  • Biology, Medicine
    Revista brasileira de psiquiatria
  • 2008
TLDR
In the last 45 years it has been possible to demonstrate that CBD has a wide range of pharmacological effects, many of which being of great therapeutic interest, but still waiting to be confirmed by clinical trials.
Medicinal Chemistry Endeavors around the Phytocannabinoids
TLDR
This review summarizes past as well as recent developments in the structure–activity relationships of phytocannabinoids.
...
...

References

SHOWING 1-10 OF 71 REFERENCES
Cannabidiol: An Overview of Some Pharmacological Aspects
TLDR
The authors present a review on the chemistry of CBD and discuss the anticonvulsive, antianxiety, antipsychotic, antinausea, and antirheumatoid arthritic properties of CBD.
Synthesis of a primary metabolite of cannabidiol.
TLDR
This work reports the first total synthesis of 7-hydroxycannabidiol 2, a primary metabolite of cannABidiol, in an eight-step procedure, which produces numerous, potentially therapeutic pharmacological effects.
The Pharmacological Actions of Cannabidiol
TLDR
The current understanding of the mechanism of action of cannabidiol is discussed, focusing on some of the central and peripheral pharmacological effects of this exciting potential therapeutic agent.
New cannabidiol derivatives: synthesis, binding to cannabinoid receptor, and evaluation of their antiinflammatory activity.
TLDR
Surprisingly, it is found that hydrogenated CBD and CBD-DMH exhibit good binding to the cannabinoid receptor (CB(1), and demonstrate bioactivities different from their original compounds.
Synthesis of cannabidiols via alkenylation of cyclohexenyl monoacetate.
TLDR
The key reaction is nickel-catalyzed allylation of 2-cyclohexene-1,4-diol monoacetate with a new reagent, (alkenyl)ZnCl/TMEDA, which gives a S(N)2-type product with 94% regioselectivity in good yield.
Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide
TLDR
Results suggest that VR1 receptors, or increased levels of endogenous AEA, might mediate some of the pharmacological effects of CBD and its analogues, and (−)‐5′‐DMH‐CBD represents a valuable candidate for further investigation as inhibitor of AEA uptake and a possible new therapeutic agent.
Antitumor Effects of Cannabidiol, a Nonpsychoactive Cannabinoid, on Human Glioma Cell Lines
TLDR
Evaluating the in vitro antiproliferative ability of cannabidiol (CBD), a nonpsychoactive cannabinoid compound, on U87 and U373 human glioma cell lines suggests a possible application of CBD as an antineoplastic agent.
...
...